| Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy (NCT05154474) | Weprom | 2022-06-01 |
| Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase (NCT05143840) | University of Alabama at Birmingham | 2022-04-22 |
| Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL (NCT04260022) | Ascentage Pharma Group Inc. | 2020-01-09 |
| Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response. (NCT03578367) | Novartis Pharmaceuticals | 2018-11-22 |
| The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) (NCT02269267) | Medical College of Wisconsin | 2014-12-18 |
| Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit (NCT01050946) | Medical College of Wisconsin | 2009-07-01 |
| Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects (NCT00759837) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| Safety Assessment of a Multipeptide-gene Vaccine in CML (NCT00455221) | Tehran University of Medical Sciences | 2008-02-01 |
| Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers (NCT00539656) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-12-20 |
| An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase (NCT00538109) | King Faisal Specialist Hospital & Research Center | 2007-10-01 |
| Prospective Database for Chronic Myelogenous Leukemia (NCT00538447) | King Faisal Specialist Hospital & Research Center | 2007-06-01 |
| Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase (NCT00449761) | Novartis Pharmaceuticals | 2007-02-23 |
| Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) (NCT00406393) | Medical College of Wisconsin | 2006-11-01 |
| Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor (NCT00393380) | The Emmes Company, LLC | 2006-09-01 |
| Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib (NCT00320190) | Bristol-Myers Squibb | 2006-08-01 |
| Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy (NCT00264160) | Novartis Pharmaceuticals | 2006-05-01 |
| T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation (NCT00306332) | Radboud University Medical Center | 2006-03-01 |
| A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate (NCT00298987) | Bristol-Myers Squibb | 2006-02-01 |
| Post Transplant Donor Lymphocyte Infusion (NCT00167180) | Masonic Cancer Center, University of Minnesota | 2004-01-01 |
| High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML) (NCT00050531) | M.D. Anderson Cancer Center | 2003-04-01 |
| Randomized Double Cord Blood Transplant Study (NCT00067002) | M.D. Anderson Cancer Center | 2003-04-01 |
| AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™ (NCT00058747) | Agenus Inc. | 2003-03-01 |
| Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia (NCT00040105) | M.D. Anderson Cancer Center | 2002-10-01 |
| Stem Cell Transplant for Hematological Malignancy (NCT00176930) | Masonic Cancer Center, University of Minnesota | 2001-10-01 |
| Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) (NCT00034684) | Merck Sharp & Dohme LLC | 2001-07-01 |
| Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase (NCT00027144) | University of Connecticut | 2000-12-01 |
| Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia (NCT00167167) | Masonic Cancer Center, University of Minnesota | 1995-12-01 |
| Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies (NCT00186342) | Stanford University | 1992-09-01 |